JW (Cayman) Therapeutics Co. Ltd (2126.HK)
HKD 1.3
(0.0%)
HKD 1.3
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -398.41 Million | -536.72 Million | -561.19 Million | -261 Million | -188.92 Million | -106.22 Million |
| Net Income | -767.99 Million | -846.13 Million | -702.32 Million | -1.66 Billion | -633.25 Million | -272.61 Million |
| Depreciation & Amortization | 99.83 Million | 81.36 Million | 46.32 Million | 23.16 Million | 17.05 Million | 5.1 Million |
| Deferred income taxes | - | -68.44 Million | -60.58 Million | -133.29 Million | 3.43 Million | - |
| Stock-based compensation | 34.96 Million | 82.5 Million | 89.37 Million | 134.25 Million | 15.44 Million | - |
| Change in working capital | 3.18 Million | -14.06 Million | -28.78 Million | -955 Thousand | -18.87 Million | -195 Thousand |
| Other non-cash items | -21.61 Million | 228.04 Million | 94.8 Million | 1.37 Billion | 427.27 Million | 161.47 Million |
| Investing Cash Flow | 9.9 Million | -124.08 Million | -137.13 Million | -91.9 Million | -117.55 Million | -44.14 Million |
| Investments in PPE | -14.58 Million | -76.87 Million | -73.08 Million | -124.23 Million | -101.94 Million | -44.14 Million |
| Acquisitions | - | - | - | 45.3 Million | - | - |
| Investment purchases | - | -23.55 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 22.31 Million | -23.65 Million | -64.04 Million | -12.97 Million | -15.6 Million | -501 Thousand |
| Financing Cash Flow | 275 Thousand | 112.35 Million | -30.62 Million | 2.85 Billion | 414.04 Million | 249.82 Million |
| Debt repayment | -27.7 Million | -115.75 Million | -13.02 Million | -11.79 Million | -45.29 Million | -2.64 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 27 Thousand | 94 Thousand | 697 Thousand | 2.14 Billion | - | - |
| Other Financing Activities | -12.38 Million | 228.01 Million | -18.29 Million | 731.01 Million | 459.34 Million | 252.46 Million |
| Accounts receivables | 5.3 Million | -5.3 Million | - | - | - | - |
| Accounts payables | - | 11.03 Million | - | - | - | - |
| Inventory | 5.38 Million | -8.75 Million | -28.78 Million | -955 Thousand | - | - |
| Other working capital | -7.49 Million | -11.03 Million | 78.56 Million | 17.62 Million | -18.87 Million | -195 Thousand |
| Cash at beginning of period | 1.38 Billion | 1.83 Billion | 2.63 Billion | 254.86 Million | 133.66 Million | 21.2 Million |
| Cash at end of period | 1 Billion | 1.38 Billion | 1.83 Billion | 2.63 Billion | 254.86 Million | 133.66 Million |
| Capital Expenditure | -14.58 Million | -76.87 Million | -73.08 Million | -124.23 Million | -101.94 Million | -44.14 Million |
| Effect of forex changes on cash | 10.81 Million | 97.38 Million | -67.25 Million | -130.78 Million | 13.63 Million | 13.01 Million |
| Net cash flow / Change in cash | -377.42 Million | -451.06 Million | -796.19 Million | 2.37 Billion | 121.2 Million | 112.46 Million |
| Free Cash Flow | -412.99 Million | -613.59 Million | -634.28 Million | -385.24 Million | -290.86 Million | -150.37 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -240.26 Million | -767.99 Million | -387.58 Million | -380.41 Million | -846.13 Million | -416.88 Million |
| Depreciation & Amortization | 46.88 Million | 99.83 Million | 50.31 Million | 49.51 Million | 81.36 Million | 39.99 Million |
| Deferred income taxes | - | - | - | - | -68.44 Million | -19.46 Million |
| Stock-based compensation | 18.55 Million | 34.96 Million | 3.01 Million | 31.95 Million | 82.5 Million | 33.53 Million |
| Change in working capital | - | 3.18 Million | 3.18 Million | - | -14.06 Million | -25.09 Million |
| Other non-cash items | -13.38 Million | -21.61 Million | 170.67 Million | 60.91 Million | 228.04 Million | 202.44 Million |
| Investing Cash Flow | -12.94 Million | 9.9 Million | -7.61 Million | 17.51 Million | -124.08 Million | -42.12 Million |
| Investments in PPE | -2.86 Million | -14.58 Million | -5.64 Million | -6.76 Million | -76.87 Million | -49.9 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -23.55 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10.07 Million | 22.31 Million | -1.96 Million | 24.27 Million | -23.65 Million | 7.77 Million |
| Financing Cash Flow | 57.05 Million | 275 Thousand | -88.62 Million | 88.89 Million | 112.35 Million | 125.03 Million |
| Debt repayment | -62.8 Million | -27.7 Million | - | -94.45 Million | -115.75 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -1000.00 |
| Common Stock Issuance | - | 27 Thousand | - | - | 94 Thousand | - |
| Other Financing Activities | -5.75 Million | -12.38 Million | -88.62 Million | -5.55 Million | 228.01 Million | 125.03 Million |
| Accounts receivables | - | 5.3 Million | 5.3 Million | - | -5.3 Million | -5.3 Million |
| Accounts payables | - | - | - | - | 11.03 Million | - |
| Inventory | - | 5.38 Million | 5.38 Million | - | -8.75 Million | -8.75 Million |
| Other working capital | - | -7.49 Million | -7.49 Million | - | -11.03 Million | -11.03 Million |
| Cash at beginning of period | 1 Billion | 1.38 Billion | 1.27 Billion | 1.38 Billion | 1.83 Billion | 1.51 Billion |
| Cash at end of period | 869.03 Million | 1 Billion | 1.27 Billion | 1.27 Billion | 1.38 Billion | 1.38 Billion |
| Capital Expenditure | -2.86 Million | -14.58 Million | -5.64 Million | -6.76 Million | -76.87 Million | -49.9 Million |
| Effect of forex changes on cash | 7.22 Million | 10.81 Million | -10.36 Million | 21.17 Million | 97.38 Million | -53.3 Million |
| Net cash flow / Change in cash | -136.87 Million | -377.42 Million | - | -110.44 Million | -451.06 Million | -136.39 Million |
| Free Cash Flow | -191.07 Million | -412.99 Million | -166.03 Million | -244.79 Million | -613.59 Million | -215.9 Million |
ENMHF
603897
EXICOM
TWCI
AHL-PC
NTAC